INTRODUCTION
citrate or injected gonadotropins (1-4). However, few reports are available to show whether this practice really does raise pregnancy rates or birth rates, and if patients with and without the 3 risk factors identiWomen with a significant luteal phase defect on endometrial biopsy were treated with clomiphene fied above.
citrate. Patients who ovulated were treated first with clomiphene citrate and then with gonadotropins if no follicles were induced or if pregnancy did not occur.
MATERIALS AND METHODS
Pergonal (Serono Laboratories, Randolph, Massachussetts) was used exclusively for the gonadotropin stimulation. The dose was determined by a protocol in which Study Design patients were started on 150 IU of Pergonal per day This study was approved by the Institutional Review for 4 days, with the dosage adjusted subsequently. The Board. In this retrospective study we reviewed the dose of clomiphene citrate was based on physician records of women who had undergone IUI at the Clevepreference, but was used in increasing doses up to 200 land Clinic Foundation between January 1993 and mg daily. December 1995. These were the first 3 years in which data collection for these patients was standardized at Sperm Preparation our institution. During this period, 533 women underwent 1728 IUI cycles using sperm from their partner.
Semen specimens were obtained by masturbation In our concurrent study, full-term pregnancy rates were after 2-3 days of sexual abstinence. Both manual and analyzed for relationship with pre-treatment clinical computer-assisted semen analysis were performed. and semen characteristics (preceding manuscript).
Complex motion parameters were assessed using a In this study, we restricted the sample to patients Motion Analysis VP-50 semen analyzer (Motion Analfor whom all ovulatory management, age, pelvic surysis Corporation, Santa Rosa, California). Endtz test gery, and sperm motility were available. We identified (myeloperoxidase staining) was performed on all spec-512 such patients who had undergone 1576 IUI cycles.
imens in which round cell concentrations exceeded 1 ϫ 10 6 mL, in order to measure the presence of granulocytes. Sperm were isolated using a modified
Patient Evaluation
Percoll-wash (Irvine Scientific, Santa Ana, California). The final sperm pellet was then re-suspended in a All medical records included findings from pretreatment history and physical examinations. Menvolume of 0.4 ml human tubal fluid. Post-wash analysis was performed on a small, well-mixed aliquot of the strual disorders were diagnosed if cycle duration was Ͼ32 days or Ͻ21 days, or if the duration of menstrual specimen, and repeat manual analysis was performed on all specimens which had Ͼ1 ϫ 10 6 round cells on flow was Ͼ7 days. Dysmenorrhea was assessed for presence and severity, and was graded as absent, mild, pre-wash analysis. moderate, or severe based on subjective patient reporting. Prior contraceptive use, and the type of conInsemination Procedures traception were recorded. Prior fertility history was elucidated. History of previous laparoscopy or open Intrauterine insemination was performed using a simple catheter with the patient in lithotomy position. pelvic surgery, and pertinent surgical findings and treatments were obtained.
Insemination procedures were performed 36 hrs following gonadotropin administration or on the day after Pelvic examinations were performed on all patients. Hysterosalpingograms were obtained when clinically urinary LH kit readings were positive. indicated. Endometrial biopsies were also obtained when clinically indicated. Diagnostic laparoscopy was Statistical Analysis performed when clinically indicated, and corrective pelvic surgery was performed by laparoscopic or open Cycles of IUI that did not result in a live delivery were considered unsuccessful. Multivariate GEE (gensurgical procedures as appropriate. We also collected data on ovulatory management, defined as the modality eralized estimating equation) logistic regression models tested the effect of stimulation in addition to other of hormonal ovulatory stimulation used in each IUI cycle. Three categories of management were defined: significant risk factors. Odds ratios and their 95% confidence intervals were calculated. Fisher's exact test 1) no ovulatory stimulation; 2) stimulation with clomiphene citrate at any dosage; and 3) stimulation with was used to determine if stimulation affected live birth rates within each group classified by the risk factors. injectable gonadotropins at any dosage. (Figure 1 ). Five subsets were considered: 1) those with no risk benefit (P ϭ 0.02), with 83 deliveries resulting from 1087 stimulated IUI cycles (7.6%), compared with 23 factors; 2) women older than 37.7 years with a history of corrective pelvic surgery; 3) women with a history deliveries out of 489 unstimulated cycles (4.7%).
Treatment results for patients who underwent singleof corrective pelvic surgery and no other risk factors; 4) women older than 37.7 with a history of corrective modality ovulatory management (a single method used throughout their treatment period) are summarized in pelvic surgery; and 5) all women whose partner's postwash sperm motility was less than 40%. Table II. No ovulatory stimulation was used among 100 In IUI cycles with no risk factors, 34 pregnancies were achieved from 220 stimulated cycles (15.5%), patients, who received 286 cycles of IUI, and achieved 23 pregnancies, resulting in 18 deliveries. Their per compared to 10 pregnancies among 127 unstimulated cycles (7.9%). The difference of 7.6% was statistically cycle pregnancy rate was 8.0%, and the individual cycles were statistically significant. When the only 2 risk factors were advanced female age and pelvic surgery, 18 pregnancies were achieved rates. Surgical correction for pelvic abnormalities also out of 320 stimulated cycles of IUI (5.6%), versus lowered the chance of success with IUI; again, when 1 pregnancy achieved among 86 unstimulated cycles pelvic surgery was the only risk factor, ovulatory stim-(1.2%; P ϭ 0.09). Because this difference was relaulation conferred no benefit. Poor sperm motility after tively large, yet not statistically significant, we pertherapeutic semen wash was virtually always associformed a post-hoc power calculation to determine ated with IUI failure, regardless of whether or not whether we could have found a significant difference.
ovulatory stimulation was employed. The only patients We found that our sample had only 72% power to with pre-treatment risk factors who may have benefited detect the observed difference. Nomograms were confrom ovulatory stimulation were older patients who structed to compare predicted live delivery rates by had a history of corrective pelvic surgery. However, age with and without ovulatory stimulation among our study lacked the necessary statistical power to patients with different combinations of pre-treatment prove a difference in percycle delivery rates between risk factors (Figure 2) . stimulated (5.6%) and unstimulated (1.2%) IUI cycles in this group, largely because of the discrepancy in the numbers of stimulated and unstimulated cycles DISCUSSION (320 and 86, respectively). The majority of patients tried only one method of We found older women had less success with IUI, ovulatory management during their attempts to become a finding consistent with that of other studies (1-3) . pregnant. Our data suggest patients who tried more When advanced age was the sole risk factor, ovulatory than one method of ovulatory management had results stimulation did not substantially improve live delivery similar to those of the patients who stayed with a single method, and hence we believe they probably constitute similar populations. The age at which the woman presents for assisted reproduction is beyond the physician's control, as is her history of pelvic surgery. Of the 3 pre-treatment risk factors which we identified, only sperm motility might potentially be improved by the fertility clinic. As demonstrated by our treatment outcomes, this factor appears to carry the highest risk of failure. Anecdotally, among our entire study population (from both studies) of 533 women undergoing 1728 IUI cycles, only one live delivery was achieved with sperm having a post-wash motility of less than 40%, and in that case, the post-wash motility was 39%.
Our study has several of the inherent limitations of retrospective research. We did not assess patient's treatment histories prior to the 3-year study period.
Although previous treatment failure might be an indein the woman and poor post-wash sperm motility are all predictors of poor IUI success rates, and the risks pendent risk factor for future failures, data from our multivariate analysis of pre-treatment risk factors does of multiple factors are cumulative. Poor post-wash sperm motility in combination with either of the other not appear to support this; the 12% of patients who underwent more than 6 IUI cycles continued to achieve two risk factors has been associated with a 0% success rate. per-cycle success rates comparable to those of their initial cycles. Conversely, patient's at the highest risk Men with poor post-wash sperm motility should be evaluated for correctable conditions. If none is present, for IUI treatment failure may have been selectively moved on to IVF. Treatment biases were present as and if the woman has one or both of the female risk factors, the couple should be counseled that IUI will well, as patients physicians employed ovulatory stimulation when they empirically believed it would be benehave little chance of success, regardless of whether ovulatory stimulation is employed, and they should be ficial.
The failure to demonstrate a benefit to ovulatory advised to consider IVF or ICSI. stimulation among IUI patients with multiple pre-treatment risk factors may indicate their risk factors were ACKNOWLEDGMENTS poorly quantifiable and eluded identification during an otherwise exhaustive retrospective review of their
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